Validity of intravenous indocyanine green injection as a diagnostic tool for soft tissue assessment in shoulder and elbow arthroscopic surgery

Asan Medical Center0 个研究点目标入组 110 人开始时间: 待定最近更新: 2022年11月28日

试验速览

暂无简介。

•1) Patients with chronic or recurrent lateral epicondylitis of the main node corresponding to indications for surgery
•2) Patients with rupture of the rotator cuff of the shoulder joint corresponding to surgical treatment indications
•3) Patients with systemic diseases who do not have a reason for disqualification from surgery and contrast agent injection
•4) Patients who are willing to voluntarily agree in writing after receiving an explanation of the purpose, method, etc. of this study, comply with the test plan, and are willing to visit the hospital for the evaluation of observation items.

•1) Patients with inflammatory or rheumatoid arthritis
•2) Patients with joint stiffness due to deformation of the humerus, radial bone, and ulnar bone that make up the main section
•3) Patients with advanced arthritis who are indications for joint replacement
•4) Patients with observed soft tissue lesions other than lateral epicondylitis
•5) Patients with soft tissue lesions other than shoulder joint rotator cuff rupture observed
•6) Those who have been diagnosed with the following diseases and find it difficult to proceed with the operation
•A. Uncontrolled diabetes, high blood pressure
•B. Severe mental illness
•c. Severe cirrhosis, renal failure, heart failure
•7) Those who are deemed inappropriate for clinical trials by the investigator responsible for the trial or other researchers
•8) Patients who are not suitable for the administration of indocyanin green
•A. Patients with a predisposition of hypersensitivity to the present drug
•B. Patients with iodine hypersensitivity
•C. Patients with a predisposition to allergies

发起方